Cerus Corp. Stock
Price
Target price
€1.77
€1.77
-3.450%
-0.062
-3.450%
€3.82
09.01.26 / Tradegate
WKN: 905249 / Symbol: CERS / Name: Cerus Corp / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cerus Corp. Stock
Heavy losses for Cerus Corp. today as the stock fell by -€0.062 (-3.450%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Cerus Corp. stock is not clear.
With a target price of 3 € there is a hugely positive potential of 69.78% for Cerus Corp. compared to the current price of 1.77 €.
Pros and Cons of Cerus Corp. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cerus Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cerus Corp. | -3.450% | 4.804% | 10.714% | 8.272% | 0.856% | -29.909% | -70.793% |
| Atricure Inc. | 3.430% | 9.036% | 9.697% | -41.613% | 6.471% | -41.613% | -20.961% |
| SI-BONE Inc | -1.120% | 5.988% | 8.589% | 28.261% | 4.734% | - | - |
| Orasure Tech | 6.600% | 11.881% | 6.604% | -36.517% | 9.709% | -50.000% | -76.821% |
Comments
Cerus Co. (NASDAQ: CERS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) had its price target lowered by analysts at Stifel Nicolaus from $6.00 to $3.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) had its price target raised by analysts at Cantor Fitzgerald from $3.00 to $4.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CERS provided by MarketBeat